Lecanemab (brand name Leqembi) is used to slow disease progression of Alzheimer’s disease in people with mild cognitive impairment or mild dementia.
This study establishes the utility of radiomics to differentiate Parkinson's disease and atypical parkinsonian syndromes using routine T1-weighted images.doi:10.1007/s00330-021-07979-7Tupe-Waghmare, PriyankaSymbiosis Center for Medical Image Analysis and Symbiosis Institute of Technology, Symbiosis ...
The heart calcium score, which you would normally get through a scan of the heart. Alzheimer's disease before any clinical symptoms have been manifest. Predicting heart attacks and strokes. Hyperlipidemia. And seven years before any symptoms of Pa...
Distinguishing between Parkinson's disease (PD) and essential tremor (ET) can be challenging sometimes. Although positron emission tomography can confirm PD diagnosis, its application is limited by high cost and exposure to radioactive isotopes. Patients with PD exhibit loss of the dorsal nigral ...